D R Cornblath - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

D R Cornblath

Showing results (141-150 of 145) with videos related to

Pageof 15

Sort By:

You have reached the last page of results.This site can display upto 145 results.

Neurology|July 15, 2011

Dominant GDAP1 mutations cause predominantly mild CMT phenotypesM Zimoń, J Baets, G M Fabrizi, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2013

Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coinP Alberti, E Rossi, D R Cornblath, et al.

Neurology|September 28, 2007

Patterns of Guillain-Barre syndrome in children: results from a Mexican populationI Nachamkin, P Arzarte Barbosa, P Arzate Barbosa, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 23, 2012

The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findingsG Cavaletti, D R Cornblath, I S J Merkies, et al.

European Journal of Cancer (Oxford, England : 1990)|May 15, 2013

Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS)D Binda, E K Vanhoutte, G Cavaletti, et al.

Pageof 15

Search research articles

Showing results (141-150 of 145) with videos related to

Sort By:

Pageof 15

You have reached the last page of results.This site can display upto 145 results.

Neurology|July 15, 2011

Dominant GDAP1 mutations cause predominantly mild CMT phenotypesM Zimoń, J Baets, G M Fabrizi, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2013

Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coinP Alberti, E Rossi, D R Cornblath, et al.

Neurology|September 28, 2007

Patterns of Guillain-Barre syndrome in children: results from a Mexican populationI Nachamkin, P Arzarte Barbosa, P Arzate Barbosa, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 23, 2012

The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findingsG Cavaletti, D R Cornblath, I S J Merkies, et al.

European Journal of Cancer (Oxford, England : 1990)|May 15, 2013

Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS)D Binda, E K Vanhoutte, G Cavaletti, et al.

Pageof 15